Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 10.95
+0.65 (6.31%)
Nov 5, 2026, 3:04 PM CST
Guanhao Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 222.53 | 160.6 | 106.78 | 105.14 | 126.28 | 159.31 |
Cash & Short-Term Investments | 222.53 | 160.6 | 106.78 | 105.14 | 126.28 | 159.31 |
Cash Growth | 57.34% | 50.41% | 1.56% | -16.74% | -20.73% | 1.99% |
Accounts Receivable | 51.82 | 52.45 | 59.55 | 61.14 | 71.98 | 106.71 |
Other Receivables | 1.57 | 2.96 | 2.21 | 13.36 | 8.74 | 11.04 |
Receivables | 53.39 | 55.42 | 61.75 | 74.51 | 80.72 | 117.75 |
Inventory | 61.99 | 77.71 | 78.46 | 71.6 | 61.68 | 140.55 |
Prepaid Expenses | - | 0.43 | - | - | - | - |
Other Current Assets | 41.98 | 31.45 | 18.8 | 16.03 | 30.22 | 17.81 |
Total Current Assets | 379.88 | 325.61 | 265.79 | 267.28 | 298.89 | 435.41 |
Property, Plant & Equipment | 329.95 | 332.47 | 332.47 | 252.04 | 214.6 | 245.54 |
Long-Term Investments | 15 | 15.19 | 22.49 | 32.08 | 32.56 | 74.22 |
Goodwill | - | - | - | - | - | 214.33 |
Other Intangible Assets | 66.46 | 71.81 | 72.7 | 78.66 | 87.49 | 64.14 |
Long-Term Deferred Tax Assets | 19.53 | 17.66 | 18.42 | 14.97 | 13.16 | 41.44 |
Long-Term Deferred Charges | 37.44 | 33.87 | 29.88 | 24.17 | 23.58 | 23.66 |
Other Long-Term Assets | 9.02 | 9.92 | 12.65 | 9.41 | - | - |
Total Assets | 857.28 | 806.53 | 754.4 | 678.59 | 670.27 | 1,099 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 11.8 | 20.13 | 35.65 | 29.32 | 2.16 | 1.88 |
Accrued Expenses | 15.36 | 65.05 | 59.45 | 58.01 | 52.96 | 83 |
Short-Term Debt | 5 | 15 | 20.01 | 24.52 | 49.05 | 51.56 |
Current Portion of Long-Term Debt | 5.07 | 2.22 | 0.09 | - | - | 54.69 |
Current Portion of Leases | - | 3.96 | 5.64 | 6.07 | 7.49 | 9.51 |
Current Income Taxes Payable | 5.66 | 3.4 | 4.71 | 3.96 | 13.72 | 14.62 |
Current Unearned Revenue | 27.18 | 31.71 | 28.76 | 21.97 | 28.29 | 17.1 |
Other Current Liabilities | 59.31 | 47.06 | 23.69 | 28.86 | 35.32 | 29.91 |
Total Current Liabilities | 129.38 | 188.54 | 177.99 | 172.72 | 188.99 | 262.27 |
Long-Term Debt | 113.64 | 103.89 | 76 | 12.02 | - | - |
Long-Term Leases | 0.23 | 1.85 | 6.62 | 12.06 | 22.52 | 35.62 |
Long-Term Unearned Revenue | 17.3 | 18.21 | 19.43 | 20.65 | 22.85 | 40.94 |
Long-Term Deferred Tax Liabilities | 7.22 | 5.42 | 6.77 | 4.9 | 4.97 | 11.74 |
Other Long-Term Liabilities | - | 0.8 | - | - | - | - |
Total Liabilities | 267.77 | 318.72 | 286.81 | 222.33 | 239.33 | 350.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 274.7 | 265.16 | 265.16 | 265.16 | 265.16 | 265.16 |
Additional Paid-In Capital | 683.67 | 598.03 | 594.54 | 600.27 | 600.27 | 597.71 |
Retained Earnings | -230.66 | -246.6 | -270.95 | -298.37 | -329.37 | -21.57 |
Comprehensive Income & Other | -46.76 | -46.51 | -46.39 | -46.46 | -50.71 | -57.38 |
Total Common Equity | 680.94 | 570.07 | 542.36 | 520.59 | 485.34 | 783.92 |
Minority Interest | -91.42 | -82.25 | -74.77 | -64.33 | -54.4 | -35.76 |
Shareholders' Equity | 589.51 | 487.82 | 467.59 | 456.26 | 430.94 | 748.16 |
Total Liabilities & Equity | 857.28 | 806.53 | 754.4 | 678.59 | 670.27 | 1,099 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 123.94 | 126.93 | 108.35 | 54.67 | 79.06 | 151.38 |
Net Cash (Debt) | 98.59 | 33.68 | -1.57 | 50.47 | 47.22 | 7.93 |
Net Cash Growth | 364.23% | - | - | 6.88% | 495.52% | - |
Net Cash Per Share | 0.37 | 0.12 | -0.01 | 0.20 | 0.18 | 0.03 |
Filing Date Shares Outstanding | 266.33 | 265.16 | 265.16 | 265.16 | 265.16 | 265.16 |
Total Common Shares Outstanding | 266.33 | 265.16 | 265.16 | 265.16 | 265.16 | 265.16 |
Working Capital | 250.5 | 137.07 | 87.8 | 94.56 | 109.9 | 173.14 |
Book Value Per Share | 2.56 | 2.15 | 2.05 | 1.96 | 1.83 | 2.96 |
Tangible Book Value | 614.48 | 498.25 | 469.66 | 441.93 | 397.85 | 505.45 |
Tangible Book Value Per Share | 2.31 | 1.88 | 1.77 | 1.67 | 1.50 | 1.91 |
Buildings | - | 392.94 | 392.83 | 225.53 | 239.59 | 239.59 |
Machinery | - | 99.79 | 99.41 | 99.17 | 101.29 | 106.02 |
Construction In Progress | - | 18.03 | 2.54 | 73.99 | 2.8 | 2.41 |